Close

Monthly Archives: June, 2016

Vela Diagnostics Announces Launch of CE-IVD HCV Genotyping Next-Generation Sequencing Assay

Vela Diagnostics announced that the Next-Generation Sequencing (NGS)-based Sentosa® SQ HCV Genotyping Assay is now CE marked for in-vitro diagnostic use. It has been...

GE Healthcare Launches New Molecular Imaging Systems That Can Help Quantitative Care and Research

GE Healthcare showcased new molecular imaging technologies at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2016 that will enable clinicians to deliver...

Novartis announce safety data of Revolade in adults with chronic immune thrombocytopenia

Novartis announced data from the largest study of its kind confirming the long-term safety profile of Revolade (eltrombopag) in adults with chronic immune (idiopathic)...

Terumo Cardiovascular Systems says FDA lifts all remaining shipping restrictions at it’s Ann Arbor F

Terumo Corporation announced that Terumo Cardiovascular Systems received notice from the U.S. FDA that it has successfully completed the second and final phase of...

Varian Medical Systems and Russian Proton Therapy Center Achieve Milestone With Cyclotron Installati

Russia's first dedicated proton therapy treatment center achieved a major milestone this week with the installation of the cyclotron by equipment supplier Varian Medical...

Philips and Rostock University collaborate to deliver networked cardiac care across Germany

Saudi Aramco has signed a Memorandum of Understanding (MoU) with GE and Cividale SpA of Italy to build the Middle East and North Africa’s...

PnuVax Inc to acquire yellow fever vaccine intellectual property from GE Healthcare

PnuVax Incorporated a vaccine and biopharmaceutical company, and GE Healthcare’s Life Sciences business announced  that they have entered an agreement under which PnuVax can...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read